+351 21 151 71 00

A Especialidade

Mensagem de Boas Vindas

Caros colegas,
No triénio que se inicia, comprometemo-nos a dinamizar a formação em Doenças Infecciosas, a uniformizar e clarificar os critérios de avaliação e progressão na carreira, e a estimular a literacia em saúde. Pretendemos concretizar o nosso projecto de forma inclusiva e transparente, garantindo um futuro mais promissor para a nossa especialidade.
A Direção do Colégio de Doenças Infecciosas

Membros da Direcção

ANA PAULA DIAS PROENÇA
ANA RITA BRAS MARTINS FAISCA
RAQUEL MARIA RIBEIRO TAVARES VENTURA – Presidente
PEDRO MIGUEL TAVARES BARRETO MAGALHÃES CRESPO
JOANA CATARINA GOUVEIA BATISTA
JOANA MARGARIDA ALMEIDA ALVES
CATARINA PAIS RODRIGUES DE OLIVEIRA PAULO
ANDRÉ DA SILVA MARQUES PINTO
FÁBIO COTA MEDEIROS
JOÃO PAULO MACIEIRA CALDAS DA COSTA (SUPLENTE)
MARIA ISABEL VIEGAS GALVÃO CASELLA MALTEZ (SUPLENTE)

Regulamento do Colégio da Especialidade de Doenças Infecciosas

Normas de Orientação Clínica (NOCs), Links úteis, guidelines e bibliografia para os diferentes tópicos das Doenças Infecciosas

Listagem de Links úteis, guidelines e bibliografia para os diferentes tópicos das Doenças Infecciosas

 

Tema Links Ano de última actualização
VIH APECS – Recomendações de TARV nas PVVIH

https://www.apecs.pt/documentos/documento-recomendacoes-de-terapeutica-antirretroviral-nas-pessoas-que-vivem-com-vih-sida.html

 

EACS Guidelines 2023

https://www.eacsociety.org/media/guidelines-12.0.pdf

 

Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV – HIV Info

Adult and Adolescent Opportunistic Infections – What’s New in the Guidelines

 

Portaria n.º 402/2023 de 4 de dezembro
Sumário: Define os procedimentos a adotar com vista ao alargamento do acesso à Profilaxia PréExposição ao VIH (PrEP) e estabelece um regime excecional de comparticipação para os medicamentos destinados à PrEP

2023

 

 

 

 

 

2023

 

2023

Antibioterapia  

Duração da Terapêutica Antibiótica em Patologia Infeciosa – DGS

 https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/0062014-de-08052014-atualizada-em-17112022.aspx

 

 

Guidelines ESCMID for the treatment of infections by multi-drug resistant Gram-negative bacteria

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) – Clinical Microbiology and Infection

 

EUCAST Dosage and breakpoint tables for antibiotics

https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Dosages_v_13.0_Breakpoint_Tables.pdf

 

IDSA/ ATS Guidelines for Pneumonia

Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Tho

 

 

2023

 

 

 

 

 

 

 

2021

 

 

 

 

 

 

 

2023

 

 

 

 

 

2019

 

 

 

Hepatites Infeção por VHC – EASL

 Management of Hepatitis C Virus Infection – EASL-The Home of Hepatology.

 

Infeção por VHB

Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)

 

2020

 

 

 

2022

 

Tuberculose e Micobactérias atípicas Tuberculose

 

Manual de tuberculose e micobactérias não tuberculosas, DGS, 2020

https://www.dgs.pt/documentos-e-publicacoes/manual-de-tuberculose-e-micobacterias-nao-tuberculosas-recomendacoes-pdf.aspx

 

WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment

https://iris.who.int/bitstream/handle/10665/332397/9789240007048-eng.pdf?sequence=1

 

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

2020

 

2020

 

 

 

 

 

2020

 

 

 

 

 

 

2020

Medicina do Viajante CDC Yellow Book 2024 | Travelers’ Health

 

Fit for Travel

 

Travel vaccinations – NHS

 

Vaccination requirements and recommendations for international travellers; and malaria situation per country – 2022 edition

 

2023

 

 

 

 

 

2022

Prevenção e Controlo de Infeção Feixe de Intervenções” para a Prevenção da Infeção do Local Cirúrgico

https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/0202015-de-15122015-atualizada-a-17112022.aspx

2022
“Feixe de Intervenções” de Prevenção de Infeção Urinária Associada a Cateter Vesical

https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/norma-n-0192015-de-15122015.aspx

 

2022
“Feixe de Intervenções” de Prevenção de Infeção Relacionada com Cateter Venoso Central”

https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/norma-n-0222015-de-161220151.aspx

 

2022
“Feixe de Intervenções” para a Prevenção da Pneumonia associada à Intubação

https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/norma-n-0212015-de-16122015-atualizada-a-17112022.aspx

2023
Avaliação de risco e rastreio de Enterobacterales produtores de carbapenemases (EPC) e de Staphylococcus aureus resistente a meticilina (SAMR) à Admissão Hospitalar e durante o Internamento.

https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/norma-n-0042023-de-29052023.aspx

 

2023
Profilaxia Antibiótica Cirúrgica na Criança e no Adulto

https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/0312013-de-31122013-atualizada-a-17112022.aspx

2023
Malária WHO Guidelines for malaria

 

Out 2023

 

Pneumonia (incluindo infeção por SARS-CoV-2) What’s New | COVID-19 Treatment Guidelines

 

IDSA Guidelines on the Treatment and Management of Patients with COVID-19

 

Terapêutica Farmacológica para a COVID-19

https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/norma-n-0052022-de-28052022-atualizada-a-17082023.aspx

 

 

 

Nov2023

 

Jun 2023

 

 

2023

Sépsis Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021 2021
Infeções Genito-urinárias Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America

 

NHS Urinary tract infection (lower)

https://www.nice.org.uk/guidance/ng109/chapter/Recommendations

 

NHS Pyelonephritis antimicrobial prescribing

https://www.nice.org.uk/guidance/ng111

 

2019

 

 

 

2018

 

 

 

2018

 

Infeções Gastrointestinais/Intraabdominais Guidelines para terapêutica de C. difficile

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

 

Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea

https://academic.oup.com/cid/article/65/12/1963/4655039?login=false

 

The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections

 

The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection

 

 

 

 

2021

 

 

 

2017

 

 

 

 

 

2017

 

 

 

2017

Infeções do SNC ESCMID Guideline for treatment of acute meningitis

ESCMID guideline: diagnosis and treatment of acute bacterial meningitis – Clinical Microbiology and Infection

 

2016
Gestão de Risco Infecioso associado à imunomodulação Protocolo de Prevenção e Tratamento de Infeções Associadas à Terapêutica Imunossupressora de Doenças Autoimunes Guideline

 

Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies | Clinical Microbiology Reviews

 

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors) – ScienceDirect

 

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors) – ScienceDirect

 

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents) – ScienceDirect

 

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors) – ScienceDirect

 

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) – ScienceDirect

 

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways) – ScienceDirect

 

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4) – ScienceDirect

 

2021

 

 

 

2020

 

 

 

2018

 

 

 

 

 

 

2018

 

 

 

 

 

2018

 

 

 

 

 

2018

 

 

 

 

 

 

2018

 

 

 

 

 

2018

 

 

 

 

 

2018

Infeções Sexualmente Transmissíveis STI Treatment Guidelines

 

2021 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens

 

Guidelines for the management of symptomatic sexually transmitted infections

 

Sexually Transmitted Infections Treatment Guidelines, 2021 – PMC

 

Treatment Guidelines (Europe) – IUSTI

 

2021

 

 

2021

 

 

2021

 

 

2021

 

 

2021

Vacinação Programa Nacional de Vacinação

 

2020